Embody vs Willow: Which GLP-1 Provider Is Better?
By Iacob Pastina, Independent Researcher
Willow beats Embody overall, scoring 8.2/10 vs 7.3/10. Choose Embody for users looking for the lowest entry price with round-the-cloc. Choose Willow for users who want a balance of quality care and reasonable pric.
A side-by-side comparison of Embody and Willow covering pricing, scores, medication types, insurance, and more to help you decide.
Embody
#31 of 40Compounded GLP-1 provider with 24/7 specialist support and competitive pricing for budget-conscious users.
Visit EmbodyWillow
#8 of 40Personalized GLP-1 weight loss with ongoing clinical support. The highest verified conversion rate among comprehensive care platforms.
Visit Willow| Feature | Embody | Willow |
|---|---|---|
| Our Score | 7.3/10 | 8.2/10 |
| Starting Price | $299/mo | $299/mo |
| Medication Type | Compounded | Both |
| Insurance Accepted | No | No |
| Best For | Users looking for the lowest entry price with round-the-clock specialist support | Users who want a balance of quality care and reasonable pricing |
| Ranking | #31 | #8 |
Pros & Cons Compared
Embody
Pros
- +$149 first month is one of the lowest entry prices in the GLP-1 market — includes medication, metabolic report, and 1:1 guidance
- +Oral tirzepatide gum format available — one of the few platforms offering a non-injectable tirzepatide option for needle-phobic patients
- +24/7 specialist support included at no extra cost for questions about dosing, side effects, and progress
- +Personalized metabolic report helps you understand your body's baseline before starting treatment
Cons
- −Monthly refill price jumps to $299/mo after the first month — nearly double what competitors like Mochi ($99/mo + membership) or TrimRx ($179/mo) charge
- −Compounded medications only — no brand-name Wegovy or Zepbound available through the platform
- −Limited company transparency — founding date, headquarters, and pharmacy partners are not publicly disclosed
Willow
Pros
- +Includes monthly provider check-ins and dose adjustments at no extra cost
- +Switch between brand-name and compounded mid-treatment without restarting
- +$160/mo all-in — no consultation fees, no shipping charges, no lab surcharges
- +90%+ patient retention rate after 3 months per their published outcomes data
Cons
- −Cash-pay only — no insurance billing, though they provide superbills for FSA/HSA
- −Founded in 2024 — less track record than Ro or Hims, though growth has been fast
Our Verdict
Willow edges out Embody with a score of 8.2/10 vs 7.3/10. Willow offers both brand-name and compounded medications, giving you more flexibility. Choose Embody if you want: users looking for the lowest entry price with round-the-clock specialist support. Choose Willow if you want: users who want a balance of quality care and reasonable pricing.